Malignant histiocytosis medical therapy

	Malignant histiocytosis Microchapters
Home
Overview
Pathophysiology
Causes
Differentiating Malignant histiocytosis from other Diseases
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Malignant histiocytosis medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Malignant histiocytosis medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Malignant histiocytosis medical therapy
CDC on Malignant histiocytosis medical therapy
Malignant histiocytosis medical therapy in the news
Blogs on Malignant histiocytosis medical therapy
Directions to Hospitals Treating Malignant histiocytosis
Risk calculators and risk factors for Malignant histiocytosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Treatment with chemotherapy has been used with some success, particularly using lomustine, prednisone, doxorubicin, and cyclophosphamide.^[1]

↑ Cronin, Kim (Dec. 2006). "Deciphering the histiocytic code". DVM. Advanstar Communications: 1S–8S. Check date values in: |date= (help)